z-logo
open-access-imgOpen Access
Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency
Author(s) -
Ahmad Khodadad,
Elaheh Elahi,
Setareh Sadat Bani Hassani,
Pejman Rouhani,
Bamdad Sadeghi,
Nima Rezaei
Publication year - 2015
Publication title -
iranian journal of pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.168
H-Index - 25
eISSN - 2008-2150
pISSN - 2008-2142
DOI - 10.5812/ijp.3419
Subject(s) - δf508 , cystic fibrosis , genotype , medicine , allele , mutation , genetics , compound heterozygosity , cystic fibrosis transmembrane conductance regulator , heterozygote advantage , gene mutation , gene , genotype phenotype distinction , gastroenterology , biology
Cystic fibrosis (CF) is the most prevalent lethal autosomal recessive disease with a broad spectrum of phenotypes. Mutation of ΔF508 in the CFTR gene is the most important and lethal mutation in CF, which contains 70% of all predisposing mutations for CF worldwide.Determining frequency of genotypes with ΔF508 mutation in CFTR gene, and evaluation of correlation between genotype and phenotype of Iranian patients with CF.Thirty six patients were included in this cross sectional study. ΔF508 mutations in both alleles of the CFTR gene were checked.Among 36 pediatric patients, ΔF508 mutation was detected in 9 (25%) patients; 2 patients were heterozygous, and 7 patients homozygous for this mutation. From overall 72 tracked alleles, 11 (15.2%) were found to have ΔF508 mutations. Differences in prevalence of dyspnea and bronchiectasis were significant in homozygote group, compared with non-mutated group for ΔF508.It seems that more ΔF508 mutated alleles lead to more severe symptoms of CF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom